IP Library Granted Patent US 11,162,916
Granted Patent B2
US 11,162,916 · App. 15/883,111 · Granted Nov 2, 2021

Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte

Inventors: Michael Malecha (Muir of Ord, GB); Antony Smith (Inverness, GB); David McColl (Inverness, GB)
Assignee: Lifescan IP Holdings, LLC
G01N27/3274G01N27/26G01N27/3272G16B40/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,162,916
App. No.
15/883,111
Filed
Jan 30, 2018
Granted
Nov 2, 2021
Kind
B2
Art Unit
1795
USPC
205/777.5
Abstract

Various embodiments for methods and systems that allow for a more accurate analyte concentration with a biosensor by determining at least one physical characteristic of the sample containing the analyte and deriving one of a batch slope, sampling time, or combinations thereof to attain accurate glucose concentration.

Claims (149)

1. A method of determining an analyte concentration from a fluid sample having an analyte of interest with a biosensor having at least two electrodes and a reagent disposed on at least one electrode of the at least two electrodes, the method comprising the steps of:

a) depositing the fluid sample on any one of the at least two electrodes to start an analyte test sequence;

b) applying a first signal to the fluid sample in order to derive a hematocrit level of the fluid sample;

c) obtaining the hematocrit level of the fluid sample;

d) specifying a sampling time based on the obtained hematocrit level;

e) driving a second signal to the fluid sample, wherein the second signal is applied from the start of the analyte test sequence;

f) measuring an output signal at the specified sampling time from at least one electrode of the at least two electrodes; and

g) using a processor, calculating the analyte concentration of the fluid sample based on the measured output signal, wherein the biosensor is a test strip and the specified sampling time is either:

i) calculated using an empirically derived equation of the form:

SpecifiedSamplingTime= x 1 H x 2 +x 3

where

“SpecifiedSamplingTime” is designated as a time point in seconds from the start of the test sequence at which to sample the output signal of the test strip,

H represents the hematocrit level of the sample expressed as whole percentages;

x 1 is 4.3×10 5 (s)+/−10%;

x 2 is −3.9+/−10%; and

x 3 is 4.8 (s)+/−10%, or

ii) the specified sampling time is estimated using a stored look-up Table 1 based on the hematocrit level, expressed as whole percentages as follows:

TABLE 1

Hematocrit Level

Sampling Time (T)

(%)

(seconds)

30

5.56

31

5.46

32

5.38

33

5.32

34

5.26

35

5.2

36

5.16

37

5.12

38

5.08

39

5.06

40

5.02

41

5

42

5

43

4.98

44

4.96

45

4.96

46

4.94

47

4.92

48

4.92

49

4.9

50

4.9

51

4.9

52

4.88

53

4.88

54

4.88

55

4.86

and wherein the analyte is glucose and in which the method further comprises the step of annunciating the analyte concentration of the fluid sample.

2. The method of claim 1 , in which the steps of applying the first signal and the driving of the second signal is in sequential order.

3. The method of claim 1 , in which the step of applying of the first signal overlaps with the step of driving of the second signal.

4. The method of claim 1 , in which the step of applying of the first signal comprises the steps of directing an alternating signal to the sample so that the hematocrit level of the fluid sample is determined from an output of the alternating signal.

5. The method of claim 4 , in which the step of directing comprises the step of driving first and second alternating signals at different respective frequencies in which a first frequency is lower than a second frequency.

6. The method of claim 5 , in which the first frequency is at least one order of magnitude lower than the second frequency.

7. The method of claim 6 , in which the first frequency comprises any frequency in the range of 10 kHz to 250 kHz.

8. The method of claim 1 , in which the step of calculating of the analyte concentration is computed using the processor with an equation of the form:

G

0

=

[

I

E

-

Intercept

Slope

]

where

G 0 represents the analyte concentration of the fluid sample;

I E represents, or is, a signal value or measurement proportional to analyte concentration measured at the SpecifiedSamplingTime, quoted in nA;

Slope represents the value obtained from calibration testing of a batch of test strips of which this particular strip comes from, quoted in nA(mg/dL); and

Intercept represents the value obtained from calibration testing of a batch of test strips of which this particular strip comes from, quoted in nA.

9. The method according to claim 1 , the method further comprising the steps of:

using the processor, deriving a batch slope for the biosensor based on the hematocrit level from the obtaining step,

wherein the calculating of the analyte concentration is based on the measured output signal at the specified sampling time and the derived batch slope, and

wherein the biosensor is a test strip from a batch of test strips and the batch slope is defined as the measured or derived gradient of the line of best fit for a graph of measured glucose concentration plotted against actual glucose concentration for the batch of test strips.

10. The method of claim 9 , in which the derived batch slope is determined using the processor from an empirically derived equation of the form:

NewSlope= aH 2 bH+c

where

NewSlope represents the derived batch slope (measured in arbitrary units);

H is the measured or estimated hematocrit level of the fluid sample (measured as percent);

a is 1.4×10 −6 +/−10%,

b is −3.8×10 −4 +/−10%,

c is 3.6×10 −2 +/−10%.

11. The method of claim 10 , in which the step of calculating the analyte concentration is computed with an equation of the form:

G

0

=

[

I

E

-

Intercept

N

e

w

S

l

o

p

e

]

where

G 0 represents the analyte concentration;

I E represents a signal proportional to analyte concentration measured at the SpecifiedSamplingTime, quoted in nA;

NewSlope represents the value derived from the measured or estimated physical characteristic; and

Intercept represents the value obtained from calibration testing of the batch of test strips of which this particular strip comes from, quoted in nA.

12. A glucose meter comprising:

a housing;

a test strip port connector configured to connect to the respective electrode connectors of the test strip; and

the processor configured to perform steps b) to g) of the method of claim 1 .

13. The glucose meter of claim 12 , wherein the processor is further programmed to determine the analyte concentration of the sample based on the specific sampling time within 10 seconds of a start of the analyte test sequence.

14. A glucose measurement system comprising:

a test strip including:

a substrate; and

a plurality of electrodes connected to respective electrode connectors; and

the glucose meter according to claim 12 .

Assignments (19)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2026
From: LIFESCAN GLOBAL CORPORATION; LIFESCAN CHINA, LLC; LIFESCAN IP HOLDINGS, LLC
To: LIFESCAN ENTERPRISES LLC
Reel/Frame 075848/0012 →
SECURITY AGREEMENT Recorded Dec 8, 2025
From: LIFESCAN ENTERPRISES LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 073893/0622 →
SECURITY INTEREST Recorded Dec 8, 2025
From: LIFESCAN ENTERPRISES LLC
To: ACQUIOM AGENCY SERVICES LLC, AS COLLATERAL AGENT
Reel/Frame 073890/0305 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: ANKURA TRUST COMPANY, LLC
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0495 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0316 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSBWILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073928/0626 →
ASSIGNMENT OF PATENT SECURITY INTERESTS (1ST LIEN) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 072567/0482 →
PATENT SECURITY AGREEMENT Recorded Jan 13, 2025
From: LIFESCAN IP HOLDINGS, LLC
To: ANKURA TRUST COMPANY, LLC, AS COLLATERAL AGENT
Reel/Frame 069881/0018 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 063740, FRAME 0080 Recorded Nov 12, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 069340/0243 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 047179, FRAME 0150 Recorded Nov 11, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: ANKURA TRUST COMPANY, LLC, AS SUCCESSOR AGENT
Reel/Frame 069314/0022 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 23, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063740/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded May 22, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063712/0430 →
CORRECTIVE ASSIGNMENT TO CORRECT THE DELETING PROPERTY NUMBER 6990849, 7169116, 7351770, 7462265,7468125, 7572356, 8093903, 8486245, 8066866 AND ADD 10431140 PREVIOUSLY RECORDED AT REEL: 050839 FRAME: 0634. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 12, 2023
From: LIFESCAN SCOTLAND LTD.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064656/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050840/0006 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN SCOTLAND LTD.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050839/0634 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2018
From: MALECHA, MICHAEL; SMITH, ANTONY; MCCOLL, DAVID
To: LIFESCAN SCOTLAND LIMITED
Reel/Frame 045303/0363 →
Continuity (7)
Division 14353870
Provisional Application 61581087 · Dec 29, 2011
Provisional Application 61581089 · Dec 29, 2011
Provisional Application 61581099 · Dec 29, 2011
Provisional Application 61581100 · Dec 29, 2011
Provisional Application 61654013 · May 31, 2012
Related Publication 20180156750A1 · Jun 7, 2018